Open Access
Open access
Materials Today Advances, volume 14, pages 100214

Calcium carbonate vaterite particles for drug delivery: Advances and challenges

Publication typeJournal Article
Publication date2022-06-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor10
ISSN25900498
General Materials Science
Mechanical Engineering
Abstract
The recent successful application of lipid-based nanoparticles as delivery vehicles in COVID-19 vaccines demonstrated the superior potential of nanoparticle-based technology for targeted drug delivery in biomedicine. Among novel, rapidly advancing delivery platforms, the inorganic nano/microparticles gradually reach new heights and attract well-deserved attention among scientists and clinicians. Calcium carbonate in its vaterite form is used as a biocompatible carrier for a progressively increasing number of biomedical applications. Its growing popularity is conferred by beneficial porosity of particles, high mechanical stability, biodegradability under certain physiological conditions, ability to provide a continuous steady release of bioactives, preferential safety profile, and low cost, which make calcium carbonate a suitable entity of highly efficacious formulations for controlled drug delivery and release. The focal point of the current review is the success of the recent vaterite applications in the delivery of various diagnostics and therapeutic drugs. The manuscript highlights the nuances of drug loading in vaterite particles, connecting it with particle morphology, size, and charge of the loaded molecules, payload concentration, mono- or multiple drug loading. The manuscript also depicts recent successful methods of increasing the loading capacity developed for vaterite carriers. In addition, the review describes the various administration routes for vaterite particles with bioactive payloads, which were reported in recent years. Special attention is given to the multi-drug-loaded vaterite particles (“molecular cocktails”) and reports on their successful delivery in vitro and in vivo . • Vaterite is a safe and multifaceted delivery platform for pharmaceutical biologics. • The loading protocol is specially designed for a particular bioactive compound. • Particle freezing, combined adsorption/centrifugation, or doping increase loading. • Vaterite nanoparticles can perform targeted drug delivery in cancer treatment. • CaCO 3 is an efficient delivery system for invasive and non-invasive administration.

Citations by journals

1
2
Crystal Growth and Design
Crystal Growth and Design, 2, 6.9%
Crystal Growth and Design
2 publications, 6.9%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 6.9%
International Journal of Molecular Sciences
2 publications, 6.9%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 2, 6.9%
Frontiers in Bioengineering and Biotechnology
2 publications, 6.9%
Pharmaceutics
Pharmaceutics, 2, 6.9%
Pharmaceutics
2 publications, 6.9%
Crystallography Reports
Crystallography Reports, 2, 6.9%
Crystallography Reports
2 publications, 6.9%
Cancer Nanotechnology
Cancer Nanotechnology, 1, 3.45%
Cancer Nanotechnology
1 publication, 3.45%
Nanomaterials
Nanomaterials, 1, 3.45%
Nanomaterials
1 publication, 3.45%
Frontiers in Materials
Frontiers in Materials, 1, 3.45%
Frontiers in Materials
1 publication, 3.45%
LWT - Food Science and Technology
LWT - Food Science and Technology, 1, 3.45%
LWT - Food Science and Technology
1 publication, 3.45%
ACS Infectious Diseases
ACS Infectious Diseases, 1, 3.45%
ACS Infectious Diseases
1 publication, 3.45%
ACS Applied Nano Materials
ACS Applied Nano Materials, 1, 3.45%
ACS Applied Nano Materials
1 publication, 3.45%
Exploration
Exploration, 1, 3.45%
Exploration
1 publication, 3.45%
Heliyon
Heliyon, 1, 3.45%
Heliyon
1 publication, 3.45%
Cement and Concrete Research
Cement and Concrete Research, 1, 3.45%
Cement and Concrete Research
1 publication, 3.45%
Cancers
Cancers, 1, 3.45%
Cancers
1 publication, 3.45%
Small
Small, 1, 3.45%
Small
1 publication, 3.45%
Minerals
Minerals, 1, 3.45%
Minerals
1 publication, 3.45%
Environmental Science and Pollution Research
Environmental Science and Pollution Research, 1, 3.45%
Environmental Science and Pollution Research
1 publication, 3.45%
Separation and Purification Technology
Separation and Purification Technology, 1, 3.45%
Separation and Purification Technology
1 publication, 3.45%
CrystEngComm
CrystEngComm, 1, 3.45%
CrystEngComm
1 publication, 3.45%
Nature Communications
Nature Communications, 1, 3.45%
Nature Communications
1 publication, 3.45%
Materials Advances
Materials Advances, 1, 3.45%
Materials Advances
1 publication, 3.45%
Applied Sciences (Switzerland)
Applied Sciences (Switzerland), 1, 3.45%
Applied Sciences (Switzerland)
1 publication, 3.45%
ACS Omega
ACS Omega, 1, 3.45%
ACS Omega
1 publication, 3.45%
1
2

Citations by publishers

1
2
3
4
5
6
7
8
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 8, 27.59%
Multidisciplinary Digital Publishing Institute (MDPI)
8 publications, 27.59%
American Chemical Society (ACS)
American Chemical Society (ACS), 5, 17.24%
American Chemical Society (ACS)
5 publications, 17.24%
Elsevier
Elsevier, 4, 13.79%
Elsevier
4 publications, 13.79%
Springer Nature
Springer Nature, 3, 10.34%
Springer Nature
3 publications, 10.34%
Frontiers Media S.A.
Frontiers Media S.A., 3, 10.34%
Frontiers Media S.A.
3 publications, 10.34%
Wiley
Wiley, 2, 6.9%
Wiley
2 publications, 6.9%
Pleiades Publishing
Pleiades Publishing, 2, 6.9%
Pleiades Publishing
2 publications, 6.9%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 6.9%
Royal Society of Chemistry (RSC)
2 publications, 6.9%
1
2
3
4
5
6
7
8
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Trushina D. et al. Calcium carbonate vaterite particles for drug delivery: Advances and challenges // Materials Today Advances. 2022. Vol. 14. p. 100214.
GOST all authors (up to 50) Copy
Trushina D., Borodina T. N., Belyakov S., Antipina M. N. Calcium carbonate vaterite particles for drug delivery: Advances and challenges // Materials Today Advances. 2022. Vol. 14. p. 100214.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mtadv.2022.100214
UR - https://doi.org/10.1016%2Fj.mtadv.2022.100214
TI - Calcium carbonate vaterite particles for drug delivery: Advances and challenges
T2 - Materials Today Advances
AU - Trushina, Daria
AU - Borodina, T N
AU - Belyakov, Sergei
AU - Antipina, Maria N.
PY - 2022
DA - 2022/06/01 00:00:00
PB - Elsevier
SP - 100214
VL - 14
SN - 2590-0498
ER -
BibTex
Cite this
BibTex Copy
@article{2022_Trushina,
author = {Daria Trushina and T N Borodina and Sergei Belyakov and Maria N. Antipina},
title = {Calcium carbonate vaterite particles for drug delivery: Advances and challenges},
journal = {Materials Today Advances},
year = {2022},
volume = {14},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016%2Fj.mtadv.2022.100214},
pages = {100214},
doi = {10.1016/j.mtadv.2022.100214}
}
Found error?